David R. Bickers, MD
Credentials & Experience
- General Dermatology
- Skin Biopsy
- Skin Cancer
Education & Training
- University of Virginia School of Medicine
- Internship: University of Iowa Hospitals & Clinics
- Residency: New York University Medical Center
- Fellowship: New York University Medical Center
About David Bickers
David R. Bickers, M.D., the Carl Truman Nelson professor and chairman of the Department of Dermatology at Columbia University College of Physicians & Surgeons and director of dermatology at NewYork-Presbyterian Hospital's Columbia University Medical Center.
Dr. Bickers received his bachelor's degree from Georgetown University in 1963 and his M.D. from the University of Virginia in 1967. He was an intern in medicine at University Hospitals, University of Iowa, Iowa City, and later completed his residency training in dermatology at New York University Medical Center. During his residency, he was a National Institute of Health training fellow in dermatology, and was a guest investigator and assistant physician at The Rockefeller University Hospital. He originally joined the faculty of Columbia P&S in 1973, before accepting an appointment as Professor and Chair of Dermatology at Case Western Reserve University School of Medicine in 1977. In 1994, he returned to Columbia P&S in his current position.
Dr. Bickers is a leading researcher in environmental carcinogenesis and photobiology. The author of more than 250 scientific and clinical publications, he has written extensively on the molecular mechanisms of skin cancer and the role of sunlight in causing it as well as diseases induced by environmental sunlight exposure such as the porphyrias. In 1989, he chaired a National Institutes of Health Consensus Conference on Ultraviolet Radiation and the Skin. He is the author/or co-author of four books, including Clinical Pharmacology of Skin Disease (1984) and Photosensitivity Diseases: Principles of Diagnosis and Treatment, Second Edition (1989).
Dr. Bickers previously served as secretary-treasurer and President of the Society for Investigative Dermatology, and associate editor of the Journal of Investigative Dermatology. He has also served on several of the Society's committees.
Dr. Bickers, who is board certified in dermatology, is a member of 11 professional societies, including the American Society for Clinical Investigation, The Association of American Physicians and an Honorary member of the American Academy of Dermatology, the German Dermatological Society and the Austrian Dermatological Society. He is also a member of Alpha Omega Alpha.
- Carl Truman Nelson Professor of Dermatology
- Chair, Department of Dermatology
- Dermatologist-in-Chief, NewYork-Presbyterian Hospital/Columbia University Medical Center
- NYP Employee Plan
- Columbia University Employee Plan
*Please contact the provider’s office directly to verify that your particular insurance is accepted.
Contact & Locations
Leading researchers are exploring the connection between tea and cancer prevention and the possibility that chemicals in tea protect against sunburn and skin damage that leads to cancer. Scientists in the department were among the first to demonstrate that treatment with tea extracts could protect against ultraviolet (UV) induced skin carcinogenesis in animals. Subsequent preliminary studies have shown that topical and ingested doses of extracts from either green or black tea protect against sunburn and skin cancer induced by light. Researchers are exploring the hypothesis that tea contains photo-protective substances. Since plants are exposed to DNA-damaging UV light, researchers believe that it is likely that plants have developed their own sun protection system. Polyphenols in tea, specifically, flavonoids, may be the chemical that provides this protection. The enzyme tyrosinase converts flavonoids in green tea to black tea pigments. In humans, tyrosinase is a key enzyme that converts tyrosine to melanin pigments. Researchers plan to identify the specific components of tea that provide sun and cancer protection and to pursue studies addressing their mechanism of action. Eventually, researchers plan to conduct clinical trials on the effectiveness of tea, both as a topical agent and as a beverage, against sunburn and skin cancer.
- Environmental Carcinogenesis
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PHASE 3 EFFICACY AND SAFETY STUDY OF PATIDEGIB TOPICAL GEL, 2%, FOR THE REDUCTION OF DISEASE BURDEN OF PERSISTENTLY DEVELOPING BASAL CELL CARCINOMAS (BCCS) IN SUBJECTS WITH BASAL (P&S Industry Clinical Trial)
Apr 9 2019 - Apr 9 2024
NON-MELANOMA SKIN CANCER: A MODEL FOR IMPACT OF AGING ON AN ENVIRONMENTAL DISEASE (Federal Gov)
Sep 15 2016 - Aug 31 2021
COLUMBIA UNIVERSITY SKIN DISEASE RESOURCE-BASED CENTER (EPICURE) (Federal Gov)
Aug 1 2016 - Jul 31 2021
A PHASE II RANDOMIZED, OPEN LABEL TRIAL COMPARING THE EFFECTS OF INTERMITTENT VISMODEGIB VS. PHOTODYNAMIC THERAPY ON THE MAINTENANCE OF BENEFIT FOLLOWING 7 MONTHS OF CONTINUOUS VISMODEGIB TREATMENT IN PATIENTS WITH MULTIPLE BASAL CELL CARCINOMAS (P&S Industry Clinical Trial)
Apr 4 2013 - Apr 4 2018
MECHANISM-BASED ABROGATION OF BCC PATHOGENESIS (Federal Gov)
Apr 16 2012 - Jan 31 2018
COLUMBIA UNIVERSITY MEDICAL CENTER SKIN DISEASE RESEARCH CENTER (CUMCSDRC) (Federal Gov)
Jul 20 1997 - Jun 30 2017
A PHASE II RANDOMIZED DOUBLE BLINE PLACEBO CONTROLLED CLINICTRIAL OF GDC-0449 AND PLACEBO EACH TAKEN ONCE DAILY (P&S Industry Clinical Trial)
Jan 14 2010 - Jan 14 2015
BIOMEDICAL RESEARCH CORE CENTER ON SKIN STEM CELLS (Federal Gov)
Sep 24 2009 - Aug 31 2013
KIEHL''S CONTRACT (Private)
Feb 2 2010 - Sep 1 2012
GENETIC MECHANISMS IN SKIN DISEASES (Federal Gov)
May 30 1997 - Aug 31 2012
CHEMOPREVENTION OF BASAL CELL CARCINOMAS WITH TAZAROTENE (Federal Gov)
Jul 1 2007 - Jun 30 2011
P38MAPK IN THE PROGRESSION OF SKIN CANCER (Private)
Jan 1 2009 - Dec 31 2009
MOLECULAR PATHOGENESIS OF UVB-INDUCED SKIN CANCER (Federal Gov)
Aug 15 2004 - May 31 2009
EFFECT OF CHEMOPREVENTIVE AGENTS ON THE DEVELOPMENT OF BASAL CELL CARCINOMA(BCC)AND SQUAMOUS CELL CARCINOMAS (SCC) IN... (Federal Gov)
Aug 1 2005 - Apr 29 2009
BASAL CELL CARCINOMA --MOLECULAR PATHOGENESIS AND PREVENTION (Federal Gov)
Jul 1 2002 - Jun 30 2008